SB151 Summary

• Authorizes committee members of the Controlled Substances Prescription Database Advisory Committee to designate proxy representatives who may participate and vote in committee meetings with written proxy designations required for each meeting.

• Permits out-of-state prescription drug monitoring programs recognized by the Alliance for Prescription Drug Monitoring Programs to access Alabama's Prescription Drug Monitoring database under rules established by the State Board of Health.

• Allows the State Board of Health to use all funds collected from the $10 annual surcharge on controlled substance registration certificates exclusively for development, implementation, operation, and maintenance of the controlled substances prescription database.

• Establishes the Controlled Substances Prescription Database Advisory Committee with representatives from 12 medical, dental, pharmacy, veterinary, and related professional organizations, with requirements for diverse membership reflecting racial, gender, geographic, urban/rural, and economic diversity.

• Becomes effective on the first day of the third month following passage and approval by the Governor.